Up until the summer of 2021, the Core Informatics web page was still operating independently, listing Core Informatics as "part of Thermo Fisher Scientific." However, it appears Core Informatics has likely been fully absorbed into Thermo as of late 2021. In March 2017, Thermo Fisher Scientific acquired Core Informatics, LLC for $94 million, which was reportedly assigned to the Thermo's Analytical Instruments division. By 2020, the acquired Affymetrix solutions were rebranded to "Applied Biosystems." (Thermo had prior acquired Life Technologies in 2013, which was the byproduct of the 2008 merger of Applied Biosystems and Invitrogen in November 2008. for $14.00 per share in cash, at a purchase price of approximately $1.3 billion. In January 2016, Thermo Fisher Scientific announced the intent to acquire Affymetrix, Inc. The Galileo ADME/toxicology LIMS was quietly phased out sometime in 2014. In April 2007, Genevac was sold to Riverlake Partners, LLC, and the divestiture met FTC approval in March 2007. However, the Federal Trade Commission (FTC) ruled that this acquisition was anti-competitive with regard to centrifugal vacuum evaporators (CVEs) because "Thermo and Fisher are the only two significant suppliers of high-performance CVEs in the United States." The FTC required Fisher to divest Genevac to settle the charges of anti-competitive behavior. On May 14, 2006, Thermo Electron and Fisher Scientific announced that they would merge in a tax-free, stock-for-stock exchange, with the merged company being named Thermo Fisher Scientific the merger was announced completed on November 9. Some of Thermo Scientific's existing products are acquisitions, originating from the purchase of InnaPhase Corporation in 2004. 2.1.3 Demonstration videos and other media.
0 kommentar(er)
